AVIR logo

Atea Pharmaceuticals (AVIR) Accounts Receivable

Quarterly Accounts Receivable

N/A

September 30, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

AVIR Quarterly Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$50.00 M
AVIR quarterly accounts receivable is currently at an all-time high

3-Year Low

$4.51 M
AVIR quarterly accounts receivable is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
AVIR previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
AVIR next earnings announcement is scheduled for Feb 28, 2025

OtherAVIRbalance sheetmetrics:

Quarterly Accounts Payable

$5.79 M
AVIR quarterly accounts payable is $5.79 million

Quarterly Total Assets

$490.96 M
AVIR quarterly total assets is $490.96 million

Quarterly Total Liabilities

$32.44 M
AVIR quarterly total liabilities is $32.44 million

Quarterly Cash And Cash Equivalents

$98.46 M
AVIR quarterly cash and cash equivalents is $98.46 million

Accounts Receivable Formula

Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales

AVIR Accounts Receivable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year--
3 y3 years--
5 y5 years--

AVIR Accounts Receivable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year
5 y5-year
alltimeall time

Atea Pharmaceuticals Accounts Receivable History

DateAnnualQuarterly
Sep 2022
-
$4.51 M(-91.0%)
DateAnnualQuarterly
Jun 2021
-
$50.00 M

FAQ

  • What is the all time high quarterly accounts receivable for Atea Pharmaceuticals?

What is the all time high quarterly accounts receivable for Atea Pharmaceuticals?

Atea Pharmaceuticals all-time high quarterly accounts receivable is $50.00 M